Clinical Interchange: Moving Forward From the Status Quo for the Treatment of Soft Tissue Sarcoma: Key Questions and New Answers to Optimize Outcomes
WebcastFaculty
OVERVIEW
Clinical Interchange: Moving Forward From the Status Quo for the Treatment of Soft Tissue Sarcoma: Key Questions and New Answers to Optimize Outcomes is organized by Physicians Education Resource, LLC (PER) and will be held during Oct 31, 2017 - Oct 31, 2018.
The target audience for this medical event is directed toward medical, surgical, and radiation oncologists, as well as fellows, who manage patients with soft tissue sarcoma (STS). Nurse practitioners, physician assistants, nurses, and other healthcare professionals interested in the treatment and management of patients with STS may also participate. This CME Conference has been approved for a maximum of 2.00 AMA PRA Category 1 Credits.
Conference Objectives :
At the conclusion of this activity, you should be better prepared to:
• Detail methods to engage community-based oncologists to communicate with sarcoma specialists in the care of patients with soft tissue sarcoma in multiple lines of treatment
• Evaluate clinical circumstances that impact sequencing decision making along the disease continuum in the management of soft tissue sarcoma
• Explain disease heterogeneity in advanced soft tissue sarcomas, and its impact on treatment strategies and methods to overcome challenges to optimized diagnoses in the field
• Describe novel mechanistic approaches that have been applied to the treatment of patients with metastatic or unresectable soft tissue sarcoma
Additional details will be posted as soon as they are available.
The target audience for this medical event is directed toward medical, surgical, and radiation oncologists, as well as fellows, who manage patients with soft tissue sarcoma (STS). Nurse practitioners, physician assistants, nurses, and other healthcare professionals interested in the treatment and management of patients with STS may also participate. This CME Conference has been approved for a maximum of 2.00 AMA PRA Category 1 Credits.
Conference Objectives :
At the conclusion of this activity, you should be better prepared to:
• Detail methods to engage community-based oncologists to communicate with sarcoma specialists in the care of patients with soft tissue sarcoma in multiple lines of treatment
• Evaluate clinical circumstances that impact sequencing decision making along the disease continuum in the management of soft tissue sarcoma
• Explain disease heterogeneity in advanced soft tissue sarcomas, and its impact on treatment strategies and methods to overcome challenges to optimized diagnoses in the field
• Describe novel mechanistic approaches that have been applied to the treatment of patients with metastatic or unresectable soft tissue sarcoma
Additional details will be posted as soon as they are available.
SPECIALITIES
Oncology
Quick Links